- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT06139172
증후군 지적 및 발달 장애의 친사회적 행동 장려
The purpose of this study is to evaluate the effectiveness of an adapted, telehealth functional behavioral therapy (FBTsIDD) specifically focused on promoting appropriate communication and behavioral strategies in individuals with syndromic intellectual and developmental disorders.
Participants will be asked to complete virtual study assessments at intake and then on a monthly basis for the duration of 3-6 months. In addition, participants will attend weekly or biweekly virtual intervention visits with a study therapist.
연구 개요
상태
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
Illinois
-
Chicago, Illinois, 미국, 60612
- Autism Assessment Research Treatment and Services (AARTS) Center at Rush University Medical Center
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Age(s) 2-12 years old at time of enrollment
- Existing genetic syndrome based on clinical or genetic diagnosis and confirmed by medical records
- Documented diagnosis of global developmental delay (GDD) or intellectual disability (ID)
- estimated ID in all ranges
- Disruptive behavior challenges determined to be clinically appropriate for remote, parent-implemented coaching based on clinician determination of acuity of problem behaviors
- Caregiver who is able to consent in English.
- Parent/caregiver available for weekly intervention sessions
- Stable psychosocial and psychiatric treatments 3 months prior to baseline visit.
Exclusion Criteria:
- High levels of aggression that mitigate remote or outpatient treatment as defined by clinician judgement and/or ABC Irritability scores above 20 (i.e., higher level of care needed than provided by study procedures)
- Medical or psychiatric instability that may limit study participation
- Meaningful change in medication or psychosocial interventions 3 months prior to baseline visit
- Limitations in technology access that may hinder participation in remote trial (e.g., declining support provided by study participation)
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 하나의
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: 기능적 행동 훈련
|
Function-based treatment (FBT) is a term for behavioral intervention approaches that use objective and systematic data collection to identify the cause of challenging behavior and teach a more prosocial replacement behavior. FBTslDD incorporates standard elements of FBT protocols with adaptations made specifically to support application to the syndromic IDD population. FBTslDD will include the following steps: (1) Syndromic IDD screening; (2) Stimulus preference assessment; (3) Indirect and descriptive assessments; (4) Screening for automatic function; (5) Functional analysis (FA); and (6) FBT intervention phase. If steps 1 - 5 determine a participant's challenging behavior serves a social function, Functional Communication Training (FCT) will be administered. If steps 1 - 5 determine a participant's challenging behavior serves an automatic function Competing Stimulus Treatment (CST) will be administered. |
|
활성 비교기: 긍정적인 양육 전략 - 평소대로 치료하기
|
Using the Planned Adaptation approach, to identify proactive adaptations seeking to improve the fit of FBTsIDD with the unique needs of the syndromic IDD population. Triangulating mixed methods data from systematic video observations, questionnaires, and qualitative interviews, then the Framework for Reporting Adaptations and Modifications-Expanded24 (FRAME) will be used to develop a rich understanding of these and any additional adaptations made to the intervention when delivered by non-specialist providers within medical hubs serving syndromic IDD populations. |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Clinical Global Impression
기간: TO (Baseline), T2 (Month 2), T4 (Month 4), T6 (Month 6)
|
Overall functioning will be measured using the Clinical Global Impression for Severity (CGI-S) and Improvement (CGl-I). GCI-S will be recorded at Baseline with CGI-S and CGI-I collected at all determined visits. The CGI provides a rating of the child's global functioning, taking into account all available information (e.g., child's symptoms, behavior, functioning). The CGI-S and CGl-I will be completed by a blinded independent evaluator. |
TO (Baseline), T2 (Month 2), T4 (Month 4), T6 (Month 6)
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Parent Target Problems (PTP) Inventory
기간: TO (Baseline), T2 (Month 2), T4 (Month 4), T6 (Month 6)
|
The Parent Target Problems is a blinded rating provided by an independent evaluator and based on a caregiver interview (30-minutes at baseline; 10- to 15-minutes at follow-visits throughout the study). The independent evaluator will use the PTP interview to record the caregivers' estimate of the frequency of problematic behaviors. From this description, the independent evaluator (blind to treatment assignment) will generate a brief narrative describing the child's problem behaviors and their impact on daily functioning. The evaluator will read this back to the caregiver to provide corrections and/or add any pertinent missing information. This process will continue until the narrative represents an accurate description per caregiver report. Change on the chief concerns determined from interviews are then rated on a 9-point scale (1=normalized, 5=unchanged, 9=disastrous). The PTP has been used to measure outcomes in behavioral intervention trials. |
TO (Baseline), T2 (Month 2), T4 (Month 4), T6 (Month 6)
|
|
Aberrant Behavior Checklist, Second Edition (ABC-2)
기간: TO (Baseline), T2 (Month 2), T4 (Month 4), T6 (Month 6)
|
The Aberrant Behavior Checklist, Second Edition (ABC-2) is a widely-used symptom checklist (completed by caregivers) that measures problematic behavior across five domain subscales: irritability, social withdrawal, stereotypic behavior, hyperactivity/noncompliance, inappropriate speech. Changes in raw scores across each subscale will be tracked against caregiver reports described in the PTP. |
TO (Baseline), T2 (Month 2), T4 (Month 4), T6 (Month 6)
|
|
Adverse Event Monitoring
기간: TO (Baseline), T1 (Month 1), T2 (Month 2), T3 (Month 3), T4 (Month 4), T5 (Month 5), T6 (Month 6)
|
Adverse events will be measured at each time point, and the log used in this study will be based on adverse event logs that have already been developed for other ongoing NIH trials in our center. The adverse event log will include data on any adverse events, the onset date, intensity of event(s), relationship to study (i.e., unrelated through definitely related), end date, outcome, regulatory action taken (if necessary), and whether treatment was required. |
TO (Baseline), T1 (Month 1), T2 (Month 2), T3 (Month 3), T4 (Month 4), T5 (Month 5), T6 (Month 6)
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
- 각인 장애
- 신경학적 징후
- 중추신경계 질환
- 신경계 질환
- 신생물
- 유전병, 선천적
- 신경 행동 징후
- 신경퇴행성 질환
- 선천적 이상
- 운동 장애
- 이상, 다중
- 유전성 퇴행성 장애, 신경계
- 종양 증후군, 유전
- 신경피부증후군
- 지적 장애
- 유전 질환, X-연관
- 과오종
- 신생물, 다발성 원발성
- 피질 발달의 기형, I군
- 피질 발달의 기형
- 신경계 기형
- 성 염색체 장애
- 염색체 장애
- 선천성, 유전성, 신생아 질환 및 이상
- X-연관 지적 장애
- 레트 증후군
- 결절성 경화증
- 취약 X 증후군
- 엔젤만 증후군
- 과오종 증후군, 다발성
- 크레아틴 결핍, X- 연결
- Telomeric 22Q13 모노 절단 증후군
- 15번 염색체 15q 부분 결실
기타 연구 ID 번호
- 21012004
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .